This book focuses on exploring the relationship between spin-outs from incumbents and the patterns of innovation in general purpose technology. Do spin-outs rea
This book offers an analysis of the dynamics of the global medical device (medtech) industry from the 1960s until the present, using the approaches of business
Second Generation Cell and Gene-Based Therapies: Biological Advances, Clinical Outcomes, and Strategies for Capitalisation serves as the only volume to the mark